Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-16-006123
Filing Date
2016-08-09
Accepted
2016-08-09 06:06:53
Documents
46
Period of Report
2016-08-09

Document Format Files

Seq Description Document Type Size
1 6-K zk1618796.htm 6-K 18532
2 EXHIBIT 10.1 exhibit_10-1.htm EX-10.1 14490
3 EXHIBIT 10.2 exhibit_10-2.htm EX-10.2 48446
4 EXHIBIT 10.3 exhibit_10-3.htm EX-10.3 16244
5 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 475523
6 EXHIBIT 99.2 exhibit_99-2.htm EX-99.2 10891
  Complete submission text file 0001178913-16-006123.txt   2377587

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cgen-20160630.xml EX-101.INS 362073
8 XBRL TAXONOMY EXTENSION SCHEMA cgen-20160630.xsd EX-101.SCH 25695
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cgen-20160630_cal.xml EX-101.CAL 45968
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cgen-20160630_def.xml EX-101.DEF 74512
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgen-20160630_lab.xml EX-101.LAB 231514
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgen-20160630_pre.xml EX-101.PRE 150866
Mailing Address 72 PINCHAS ROSEN ST TEL AVIV L3 69512
Business Address 72 PINCHAS ROSEN ST TEL AVIV L3 69512 011-972-3-765-8585
COMPUGEN LTD (Filer) CIK: 0001119774 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-30902 | Film No.: 161815936
SIC: 2836 Biological Products, (No Diagnostic Substances)